Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fagerhult
Mandate

Vinge advises Fagerhult

January 08, 2019 Capital Markets and Public M&A

AB Fagerhult (publ) has entered into an agreement to acquire iGuzzini illuminazione S.p.A. for EUR 385 million on a cash and debt free basis.

After closing of the transaction, the intention is that Fagerhult will repay a bridge loan, raised to finance such part of the consideration that is not payable in Fagerhult shares, with the proceeds from a rights offering of approx. EUR 220 million.

Vinge and others advise Fagerhult. The Vinge team includes Erik Sjöman, Christian Lindhé and Ludvig Frithiof.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026